-
Loading metrics
Cost-effectiveness analysis of benmelstobart and anlotinib plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: Perspectives from the United States and China
- Wenwang Lang,
- Jiangbo Wang,
- Ming Ouyang,
- Haiqing Zhao,
- Tingting Zhou,
- Lingyue Huang
x
- Published: September 26, 2025
- https://doi.org/10.1371/journal.pone.0331338